No abstract available
Keywords:
Arava; Avsola; Azulfidine; Brenzys; Celebrex; Cosentyx; DMARDs; Enbrel; Erelzi; Eticovo; Gengraf; Hadima; Humira; IL-12/23 inhibitor; IL-17A inhibitors; Inflectra; Ixifi; Metoject; NSAIDs; Neoral; Olestyr; Orencia; Otezla; Otrexup; PDE4 inhibitors; Questran; Rasuvo; RediTrex; Remicade; Renflexis; Rinvoq; Salazopyrin; Simponi; Stelara; T-Cell activation inhibitor; TNF inhibitors; Taltz; Trexall; Xeljanz; abatacept; adalimumab; adverse effects; apremilast; biosimilars; celecoxib; certolizumab; cholestyramine; corticosteroids; cyclosporine; dosage; drug interactions; efficacy; etanercept; golimumab; infliximab; ixekizumab; lactation; leflunomide; methotrexate; pregnancy; psoriatic arthritis; safety; secukinumab; sulfasalazine; tofacitinib; upadacitinib; ustekinumab.
MeSH terms
-
Adrenal Cortex Hormones / administration & dosage
-
Adrenal Cortex Hormones / adverse effects
-
Adrenal Cortex Hormones / therapeutic use*
-
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Antirheumatic Agents / administration & dosage
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Psoriatic / drug therapy*
-
Biological Products / administration & dosage
-
Biological Products / adverse effects
-
Biological Products / therapeutic use*
-
Drug Costs
-
Drug Interactions
-
Humans
-
Phosphodiesterase 4 Inhibitors / administration & dosage
-
Phosphodiesterase 4 Inhibitors / adverse effects
-
Phosphodiesterase 4 Inhibitors / therapeutic use*
Substances
-
Adrenal Cortex Hormones
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antirheumatic Agents
-
Biological Products
-
Phosphodiesterase 4 Inhibitors